跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VILDAGLIPTINA DIAGONALIS 50 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VILDAGLIPTINA DIAGONALIS 50 MG COMPRIMIDOS EFG
Approved
STANDARD
VILDAGLIPTINA DIAGONALIS 50 MG COMPRIMIDOS EFG
Galenicum Health S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2022
Approval ID
7e48534acbd8201d
Company
Galenicum Health S.L.U.
Type
Standard
Approval Details
Approval Id
7e48534acbd8201d
Drug Cima Aemps Name
VILDAGLIPTINA DIAGONALIS 50 MG COMPRIMIDOS EFG
Register Number
87852
Holder Company Name
Galenicum Health S.L.U.
Marketing Company Name
Galenicum Health S.L.U.
Authorization Date
2022-07-21
Dosage Form
COMPRIMIDO
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Galenicum Health S.L.U.
Active Ingredients
VILDAGLIPTINA
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2022
Approval ID
7e48534acbd8201d
Type
Standard
Back to CIMA-AEMPS Approvals
